Cibc World Market Inc. Has $26.47 Million Holdings in Zoetis Inc. (NYSE:ZTS)

Cibc World Market Inc. raised its position in Zoetis Inc. (NYSE:ZTS) by 44.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 162,446 shares of the company’s stock after purchasing an additional 49,774 shares during the period. Cibc World Market Inc.’s holdings in Zoetis were worth $26,467,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Algert Global LLC boosted its position in shares of Zoetis by 29.5% during the 2nd quarter. Algert Global LLC now owns 1,924 shares of the company’s stock valued at $334,000 after purchasing an additional 438 shares in the last quarter. Quarry LP boosted its holdings in shares of Zoetis by 273.2% during the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock worth $36,000 after buying an additional 153 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Zoetis by 57.0% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 13,977 shares of the company’s stock worth $2,423,000 after buying an additional 5,073 shares during the period. AMF Tjanstepension AB increased its stake in shares of Zoetis by 23.4% in the 3rd quarter. AMF Tjanstepension AB now owns 105,376 shares of the company’s stock valued at $20,594,000 after acquiring an additional 20,001 shares in the last quarter. Finally, Czech National Bank lifted its position in shares of Zoetis by 6.1% during the 3rd quarter. Czech National Bank now owns 92,291 shares of the company’s stock valued at $18,032,000 after acquiring an additional 5,339 shares during the period. 92.80% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts have commented on ZTS shares. UBS Group assumed coverage on shares of Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target for the company. Stifel Nicolaus decreased their target price on Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. Leerink Partnrs upgraded Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. Leerink Partners assumed coverage on Zoetis in a research note on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective for the company. Finally, JPMorgan Chase & Co. upped their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $215.00.

Zoetis Trading Down 1.1 %

NYSE ZTS opened at $170.81 on Friday. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of $77.06 billion, a P/E ratio of 32.11, a PEG ratio of 2.70 and a beta of 0.89. The business has a fifty day simple moving average of $169.74 and a 200 day simple moving average of $179.54. Zoetis Inc. has a 12 month low of $144.80 and a 12 month high of $200.53.

Zoetis (NYSE:ZTS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The company had revenue of $2.40 billion for the quarter, compared to analyst estimates of $2.29 billion. During the same period last year, the firm earned $1.36 earnings per share. The firm’s revenue was up 11.6% on a year-over-year basis. On average, analysts predict that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Investors of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.17%. This is an increase from Zoetis’s previous quarterly dividend of $0.43. The ex-dividend date is Tuesday, January 21st. Zoetis’s dividend payout ratio (DPR) is presently 37.59%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.